Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2006-11-21
2006-11-21
Badio, Barbara P. (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C552S551000
Reexamination Certificate
active
07138390
ABSTRACT:
The invention relates to compounds of formula (I):wherein R is ethyl and pharmaceutically acceptable salts, solvates or amino acid conjugates thereof. The compounds of formula (I) are useful as FXR agonists.
REFERENCES:
patent: 4921848 (1990-05-01), Frigerio et al.
patent: 5061701 (1991-10-01), Pellicciari et al.
patent: 5128481 (1992-07-01), Oda et al.
patent: 5175320 (1992-12-01), Pellicciari et al.
patent: 6639078 (2003-10-01), Haffner et al.
patent: 6777446 (2004-08-01), Houze et al.
patent: 6906057 (2005-06-01), Forman et al.
patent: 6984650 (2006-01-01), Haffner et al.
patent: 6987121 (2006-01-01), Kliewer et al.
patent: 2002/0132223 (2002-09-01), Forman et al.
patent: 0 312 867 (1989-04-01), None
patent: 312867 (1989-04-01), None
patent: 0 393 493 (1990-10-01), None
patent: 1165135 (2004-09-01), None
patent: 1473042 (2004-11-01), None
patent: 1185277 (2005-10-01), None
patent: WO-2000/025134 (2000-05-01), None
patent: WO-2000/037077 (2000-06-01), None
patent: WO-2000/057915 (2000-10-01), None
patent: WO-2000/076523 (2000-12-01), None
patent: WO-2002/020463 (2002-03-01), None
patent: WO-2002/064125 (2002-08-01), None
patent: WO-2003/030612 (2003-04-01), None
patent: WO-2003/080803 (2003-10-01), None
patent: WO-2003/086303 (2003-10-01), None
patent: WO-2003/090745 (2003-11-01), None
Mi, Li-Zhi et al. 2003. “Structural Basis for Bile Acid Binding and Activation of the Nuclear Receptor FXR.”Molecular Cell. vol. 11, pp. 1093-1100.
Pellicciari, R. et al. 2002. “6alpha-Ethyl-Chenodeoxycholic Acid (6-EDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity.”J. Med. Chem. vol. 45, No. 17, pp. 3569-3572.
Badio Barbara P.
Intercept Pharmaceuticals
Wilmer Cutler Pickering Hale and Dorr LLP
LandOfFree
Steroids as agonists for FXR does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Steroids as agonists for FXR, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Steroids as agonists for FXR will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3702756